Humans with CNM caused by TTN mutation present with multiple internal nuclei, type I fiber predominance, hypotrophy and endomysial fibrosis (Ceyhan-Birsoy et al., 2013) – symptoms collectively dissimilar to that observed for the Smyd1 CKO. Here, SMYD1 is linked to centronuclear myopathy.